產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時(shí)服務(wù)熱線
產(chǎn)品概述
產(chǎn)品信息
| 名稱 | SUM149PT (人乳腺癌細(xì)胞) (STR鑒定正確) |
| 別稱 | SUM-149PT; SUM 149PT; SUM149-PT; SUM149; SUM-149; SUM 149; 149 PT; 149PT; BrCL12 |
| 種屬 | 人 |
| 生長(zhǎng)特性 | 貼壁細(xì)胞 |
| 細(xì)胞形態(tài) | 上皮細(xì)胞樣 |
| 凍存條件 | 凍存液：55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度：液氮 |
| 培養(yǎng)方案A（默認(rèn)） |
培養(yǎng)條件:
氣相：空氣，95%；CO2，5%, 溫度：37℃
|
| 推薦傳代比例 | 1:3 |
| 推薦換液頻率 | 2-3次/周 |
參考資料(來(lái)源文獻(xiàn))
| 背景描述 | The SUM149PT cell line was developed from Invasive Ductal Carcinoma from a patient with ER negative, PR negative and Her2 positive (not activated) inflammatory breast cancer. The cell line is immortal and expresses luminal cytokeratins 8, 18, and 19, which is consistent with their origin from luminal breast epithelial cells. SUM149PT has been known to form tumors in nude mice. |
| 年齡（性別） | 女性；40歲 |
| 組織來(lái)源 | 乳腺癌 |
| 細(xì)胞類型 | 腫瘤細(xì)胞 |
| 腫瘤類型 | 乳腺癌細(xì)胞 |
| 生物安全等級(jí) | BSL-1 |
| 倍增時(shí)間 | 48 hours |
STR鑒定
-
STR位點(diǎn)信息
Amelogenin X CSF1PO 12 D2S1338 20 D3S1358 17 D5S818 11 D7S820 11 D8S1179 14,16 D13S317 12 D16S539 11 D18S51 14,15 D19S433 12,14 D21S11 28,31.2 FGA 29 PentaD 8,9 PentaE 11 TH01 9.3 TPOX 9 vWA 16,18 D6S1043 18 D12S391 15,18 D2S441 12,16 -
STR鑒定圖
-
參考文獻(xiàn)
文獻(xiàn)列表
-
UCHL1 contributes to insensitivity to endocrine therapy in triple-negative breast cancer by deubiquitinating and stabilizing KLF5(2024/03/11)
作者：Juan Li, Yu Liang, Shijie Zhou
期刊：BREAST CANCER RESEARCH
DOI：10.1186/s13058-024-01800-1
影響因子 ：7.400
引用產(chǎn)品：CL-0740
-
Mutant p53 and ELK1 co-drive FRA-1 Expression to induce metastasis in breast cancer(2023/11/16)
作者：Sike Hu, Manxue Wang, Ailing Ji
期刊：FEBS LETTERS
影響因子 ：3.500
引用產(chǎn)品：CL-0740
FAQs
Q：{{item.question}}
A：{{item.answer}}
暫無(wú)數(shù)據(jù)
產(chǎn)品資料
注：百度瀏覽器無(wú)法支持掃一掃功能，請(qǐng)輸入識(shí)別碼，獲取相應(yīng)產(chǎn)品資料
識(shí)別碼示意圖
娜胡文君.png "邱國(guó)娜/胡文君")
.png "梅文強(qiáng)")
